Case Reports
Prostaglandin E1 in neonates with critical congenital heart disease
- PMID: 6183249
Item in Clipboard
Case Reports
Prostaglandin E1 in neonates with critical congenital heart disease
J Ark Med Soc.
1982 Oct.
No abstract available
Similar articles
-
Prostaglandins and the management of congenital heart disease.Am Fam Physician. 1982 Dec;26(6):127-32. Am Fam Physician. 1982. PMID: 6890758
-
Role of prostaglandin E1 and E2 in the management of neonatal heart disease.Adv Prostaglandin Thromboxane Res. 1978;4:345-53. Adv Prostaglandin Thromboxane Res. 1978. PMID: 645511 No abstract available.
-
[Anesthesia for neonates and young infants with ductus dependent cardiac malformations treated with prostaglandin E1].Masui. 1984 May;33(5):545-9. Masui. 1984. PMID: 6540818 Japanese. No abstract available.
-
Cardiovascular therapy in the newborn.Clin Invest Med. 1985;8(4):360-7. Clin Invest Med. 1985. PMID: 3907921 Review.
-
Evaluation of alprostadil (prostaglandin E1) in the management of congenital heart disease in infancy.Pharmacotherapy. 1982 May-Jun;2(3):148-55. doi: 10.1002/j.1875-9114.1982.tb04522.x. Pharmacotherapy. 1982. PMID: 6763200 Review.